NICE Advises Imcivree By Rhythm To Treat Obesity And Hunger
Imcivree, also known as setmelanotide, has been recommended by the National Institute for Health and Care Excellence (NICE) in its advice for managing obesity...
Researchers Push For Antibiotic Nod In Brazil, India, And SA
According to a paper examining the present environment for antimicrobial development in Brazil, India, and South Africa, lowering regulatory barriers to hasten the clearance...
India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High
As daily infections reached a four-month high, the Indian government's COVID-19 vaccinations touched 2 billion on July 17th. Booster doses are currently being administered...
Serum Institute Wins USFDA Nod To Export Novavax COVID Jab
The FDA has given the go-ahead to the Serum Institute of India (SII) to eventually supply a COVID-19 vaccine to the U.S. with Novavax's...
The US Has Prolonged The COVID-19 Public Health Emergency
The COVID-19 public health emergency was prolonged by the Biden administration on July 15th for a further three months. The declaration was officially renewed...
The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%
According to a recent study conducted by Tel Aviv University and Ben Gurion University of the Negev in conjunction with the Israeli Ministry of...
NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine
An early-stage clinical trial assessing an investigational vaccine to stave off Nipah virus infection has been started by the National Institute of Allergy and...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...